Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-03-06 @ 12:32 PM
Study NCT ID:
NCT01838434
Status:
COMPLETED
Last Update Posted:
2018-01-30
First Post:
2013-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2014-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-19
First Submit QC Date:
None
Study First Post Date:
2013-04-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-26
Last Update Post Date:
2018-01-30
Last Update Post Date Type:
ACTUAL